Data from Tumor Necrosis Factor-Alpha and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice

March 2023

David Surguladze, Dhanvanthri S. Deevi, Nidia Claros, Erik Corcoran, Su Wang, Mary Jane Plym, Yan Wu, Jacqueline Doody, David J. Mauro, Larry Witte, Klaus J. Busam, Bronek Pytowski, Ulrich Rodeck, James R. Tonra

epidermal growth factor receptor EGFR tumor necrosis factor-α TNFα interleukin-1 monoclonal antibody ME1 neutrophil-rich inflammation hair follicles etanercept Kineret cytokines IL-1 Enbrel anakinra

TLDR TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

The study investigates the inflammatory skin changes caused by epidermal growth factor receptor (EGFR) antibody therapy, specifically using a monoclonal antibody, ME1, in mice. This therapy led to neutrophil-rich hair follicle inflammation and lipid-filled hair follicle distensions. The cytokine tumor necrosis factor-α (TNFα) was found to be up-regulated in the affected skin regions, and its involvement in the inflammatory process was confirmed by the reduction of inflammation through the TNFα inhibitor, etanercept. Additionally, the interleukin-1 antagonist Kineret also alleviated the inflammation, suggesting that both TNFα and interleukin-1 play roles in this condition. The findings provide a basis for developing evidence-based treatments for EGFR antibody-induced skin rashes in cancer patients.

View this study on aacr.figshare.com →

Discuss this study in the Community →

Related Community Posts Join

6 / 72 results

community New and Interesting HairLoss Studies/Papers/Reviews

in Treatment 44 upvotes 5 years ago

Hair loss treatments discussed include Dutasteride with Ketoconazole, tissue engineering strategies, and androgenetic alopecia therapies. Massage doubles follicular retention, improving treatment effectiveness.

community The end of balding: We may have just found the secret to hair regrowth

in Technology 676 upvotes 4 months ago

MCL-1 is important for hair follicle stem cell survival, but its impact on human hair regrowth is unclear. Minoxidil and finasteride are the main treatments, with doubts about new discoveries leading to effective human solutions soon.

community The Real Cause Of Androgenetic Alopecia

in Research/Science 676 upvotes 10 months ago

Androgenetic alopecia is caused by DHT affecting hair growth. Finasteride and minoxidil are used to manage hair loss by blocking DHT and promoting hair growth.

community How all hormones affect our hair follicles. Not just DHT. Take a look at this paper. Prolactin, melatonin, cortisol, progesterone, testosterone and more

in Research/Science 126 upvotes 2 years ago

The conversation discusses various factors affecting hair loss, not just DHT, and mentions treatments like Minoxidil, finasteride, and melatonin. Some users report personal experiences with these treatments and hormone tests, while others speculate on the role of hormones like prolactin and cortisol in hair loss.

community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

in Research 830 upvotes 1 year ago

Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

community PP405: The Ultimate Hair Loss Drug for Complete Hair Growth

in Research/Science 206 upvotes 8 months ago

PP405 is a new hair loss treatment in phase 2 trials that may promote hair growth by increasing lactate production and activating hair follicle stem cells. It could potentially replace hormone-disrupting treatments like Minoxidil and finasteride.

Similar Research

5 / 1000+ results

research Oral Combination Treatment of Gefitinib and Sasam-Kyeongokgo: Synergistic Effects on the NCI-H520 Tumor Cell Line

January 2023 in “Applied sciences”

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

research Data from Tumor Necrosis Factor-Alpha and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice

March 2023

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

research Acne

4 citations, January 2019

Acne is a common skin condition that can be influenced by diet, lifestyle, and hormones, and requires a treatment approach that includes psychological considerations.

research Molecular Signaling Pathways in Wound-Induced Hair-Follicle Neogenesis

March 2025 in “Cells”

Understanding wound healing and signaling pathways could lead to new alopecia treatments.

research Interleukin-1 Induces Transcription of Keratin K6 in Human Epidermal Keratinocytes

90 citations, February 2001 in “The journal of investigative dermatology/Journal of investigative dermatology”

Interleukin-1 increases keratin K6 production in skin cells.